Secondary Immunodeficiency Related to Kidney Disease (SIDKD)—Definition, Unmet Need, and Mechanisms. Issue 2 (February 2022)

• Record Type: Journal Article
• Authors: Steiger, Stefanie; Rossaint, Jan; Zarbock, Alexander; Anders, Hans-Joachim
• Is Part Of: Journal of the American Society of Nephrology. Volume 33:Issue 2(2022)
• Page Start: 259
• Page End: 278
• Publication Date: 2022-02
• Subjects: kidney disease -- immunodeficiency -- infection -- chronic inflammation
• DOI: 10.1681/ASN.2021091257
• Languages: English
• ISSNs: 1046-6673

Abstract

Abstract : Kidney disease is a known risk factor for poor outcomes of COVID-19 and many other serious infections. Conversely, infection is the second most common cause of death in patients with kidney disease. However, little is known about the underlying secondary immunodeficiency related to kidney disease (SIDKD). In contrast to cardiovascular disease related to kidney disease, which has triggered countless epidemiologic, clinical, and experimental research activities or interventional trials, investments in tracing, understanding, and therapeutically targeting SIDKD have been sparse. As a call for more awareness of SIDKD as an imminent unmet medical need that requires rigorous research activities at all levels, we review the epidemiology of SIDKD and the numerous aspects of the abnormal immunophenotype of patients with kidney disease. We propose a definition of SIDKD and discuss the pathogenic mechanisms of SIDKD known thus far, including more recent insights into the unexpected immunoregulatory roles of elevated levels of FGF23 and hyperuricemia and shifts in the secretome of the intestinal microbiota in kidney disease. As an ultimate goal, we should aim to develop therapeutics that can reduce mortality due to infections in patients with kidney disease by normalizing host defense to pathogens and immune responses to vaccines.